RRM1 and lung carcinoma: Many recent works have mainly focused on whether RRM1 can be used as a molecular predictor in lung cancer by different methods of biomarker analysis, including quantitative real‐time PCR analysis, immunohistochemistry, western blot analysis, and automated quantitative analysis 7, 20, 21, 22.